- |||||||||| Fiasp (fast-acting insulin aspart) / Novo Nordisk, NovoLog (insulin aspart) / Novo Nordisk
New P3 trial, Combination therapy: onset (clinicaltrials.gov) - Feb 2, 2016 P3, N=833, Not yet recruiting,
- |||||||||| Fiasp (fast-acting insulin aspart) / Novo Nordisk, NovoLog (insulin aspart) / Novo Nordisk
New P3 trial, Combination therapy: onset (clinicaltrials.gov) - Jul 16, 2015 P3, N=1130, Not yet recruiting,
- |||||||||| Fiasp (fast-acting insulin aspart) / Novo Nordisk
Trial completion: onset (clinicaltrials.gov) - May 27, 2014 P3, N=37, Completed, Recruiting --> Completed Active, not recruiting --> Completed
- |||||||||| Fiasp (fast-acting insulin aspart) / Novo Nordisk
Enrollment closed: onset (clinicaltrials.gov) - Feb 25, 2014 P3, N=36, Active, not recruiting, Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- |||||||||| Fiasp (fast-acting insulin aspart) / Novo Nordisk
New P3 trial: onset (clinicaltrials.gov) - Dec 1, 2013 P3, N=36, Active, not recruiting,
|